Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBAT Trial: Albumin and Enoxaparin in Decompensated Cirrhosis
NCT05895136Phase 2Recruiting
- Sponsor
- European Foundation for the Study of Chronic Liver Failure
- Start
- Jul 2024
- Primary completion
- Oct 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 2 trial of albumin (human), enoxaparin in decompensated cirrhosis, sponsored by European Foundation for the Study of Chronic Liver Failure. Started Jul 2024; status: recruiting.
02
Drugs
albumin (human)enoxaparin
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on NCT05895136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05895136.